Beijing Tong Ren Tang Chinese Medicine Company Limited (3613.HK)
HKD 8.42
(0.0%)
HKD 8.42
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -868 Million HKD | 54.02% |
| 2022 | -1.88 Billion HKD | -23.24% |
| 2021 | -1.53 Billion HKD | -16.04% |
| 2020 | -1.32 Billion HKD | -37.96% |
| 2019 | -956.83 Million HKD | -74.41% |
| 2018 | -548.61 Million HKD | 26.84% |
| 2017 | -749.83 Million HKD | 5.92% |
| 2016 | -797 Million HKD | -4.97% |
| 2015 | -759.29 Million HKD | -151.77% |
| 2014 | -301.58 Million HKD | 33.61% |
| 2013 | -454.26 Million HKD | -99.17% |
| 2012 | -228.07 Million HKD | -63.73% |
| 2011 | -139.3 Million HKD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -1.72 Billion HKD | 7.77% |
| 2024 Q1 | -1.72 Billion HKD | -98.3% |
| 2023 Q2 | -1.69 Billion HKD | 2.96% |
| 2023 FY | -868 Million HKD | 54.02% |
| 2023 Q1 | -1.75 Billion HKD | 7.3% |
| 2023 Q4 | -868 Million HKD | 6.09% |
| 2023 Q3 | -924.25 Million HKD | 45.58% |
| 2022 Q1 | -633.72 Million HKD | 58.63% |
| 2022 FY | -1.88 Billion HKD | -23.24% |
| 2022 Q4 | -1.88 Billion HKD | 2.18% |
| 2022 Q3 | -1.93 Billion HKD | -228.65% |
| 2022 Q2 | -587.24 Million HKD | 7.33% |
| 2021 Q1 | -1.84 Billion HKD | -39.87% |
| 2021 FY | -1.53 Billion HKD | -16.04% |
| 2021 Q3 | -1.58 Billion HKD | 11.92% |
| 2021 Q4 | -1.53 Billion HKD | 3.33% |
| 2021 Q2 | -1.79 Billion HKD | 2.57% |
| 2020 Q3 | -1.36 Billion HKD | 13.97% |
| 2020 FY | -1.32 Billion HKD | -37.96% |
| 2020 Q1 | -1.61 Billion HKD | -69.17% |
| 2020 Q2 | -1.58 Billion HKD | 2.3% |
| 2020 Q4 | -1.32 Billion HKD | 2.98% |
| 2019 Q4 | -956.83 Million HKD | 3.96% |
| 2019 Q2 | -297.14 Million HKD | 13.1% |
| 2019 FY | -956.83 Million HKD | -74.41% |
| 2019 Q3 | -996.26 Million HKD | -235.28% |
| 2019 Q1 | -341.96 Million HKD | 37.67% |
| 2018 FY | -548.61 Million HKD | 26.84% |
| 2018 Q4 | -548.61 Million HKD | 0.0% |
| 2018 Q3 | -548.61 Million HKD | -33.16% |
| 2018 Q2 | -412 Million HKD | -121.44% |
| 2018 Q1 | 1.92 Billion HKD | 356.24% |
| 2017 Q2 | -544.54 Million HKD | -133.98% |
| 2017 FY | -749.83 Million HKD | 5.92% |
| 2017 Q4 | -749.83 Million HKD | -143.9% |
| 2017 Q1 | 1.6 Billion HKD | 301.07% |
| 2017 Q3 | 1.7 Billion HKD | 413.68% |
| 2016 Q1 | 1.29 Billion HKD | 270.75% |
| 2016 FY | -797 Million HKD | -4.97% |
| 2016 Q4 | -797 Million HKD | 0.0% |
| 2016 Q2 | -838.8 Million HKD | -164.7% |
| 2015 Q4 | -759.29 Million HKD | 0.0% |
| 2015 Q2 | -616.61 Million HKD | -158.79% |
| 2015 FY | -759.29 Million HKD | -151.77% |
| 2015 Q1 | 1.04 Billion HKD | 447.76% |
| 2014 FY | -301.58 Million HKD | 33.61% |
| 2014 Q4 | -301.58 Million HKD | 0.0% |
| 2014 Q2 | -516.45 Million HKD | -155.41% |
| 2014 Q1 | 932.06 Million HKD | 305.18% |
| 2013 Q4 | -454.26 Million HKD | 0.0% |
| 2013 Q2 | -845.82 Million HKD | -449.68% |
| 2013 Q1 | 241.88 Million HKD | 206.06% |
| 2013 FY | -454.26 Million HKD | -99.17% |
| 2012 Q4 | -228.07 Million HKD | 0.0% |
| 2012 FY | -228.07 Million HKD | -63.73% |
| 2011 FY | -139.3 Million HKD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| China Healthwise Holdings Limited | 94.47 Million HKD | 1018.724% |
| Tycoon Group Holdings Limited | 167.05 Million HKD | 619.578% |